Radical cystectomy for the treatment of T1 bladder cancer: The Canadian Bladder Cancer Network experience

Journal of the Canadian Urological Association

Volumn 5, Issue 2, 2011, Pages 83-87

  Chalasani, Venu ^a   Kassouf, Wassim ^b   Chin, Joseph L ^a   Fradet, Yves ^c   Aprikian, Armen G ^b   Fairey, Adrian S ^d   Estey, Eric ^d   Lacombe, Louis ^c   Rendon, Ricardo ^e   Bell, David ^e   Cagiannos, Ilias ^f   Drachenberg, Darrell ^g   Lattouf, Jean Baptiste ^h   Izawa, Jonathan I ^a  

^a WESTERN UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e DALHOUSIE UNIVERSITY   (Canada)

^f UNIVERSITY OF OTTAWA   (Canada)

^g UNIVERSITY OF MANITOBA   (Canada)

^h UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79953290299     PISSN: 19116470     EISSN: 19116470     Source Type: Journal    
DOI: 10.5489/cuaj.10040     Document Type: Article

References (21)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Garcia M, Jemal A, Ward EM, et al. Global Cancer Facts & Figures 2007. Atlanta, GA: American Cancer Society, 2007.
3. Schned AR, Andrew AS, Marsit CJ, et al. Histological classification and stage of newly diagnosed bladder cancer in a population-based study from the Northeastern United States. Scand J Urol Nephrol 2008:42:237-42.
4. Gardmark T, Bladstrom A, Hellsten S, et al.; members of the Swedish National Bladder Cancer Registry. Analysis of clinical characteristics, management and survival of patients with Ta T1 bladder tumours in Sweden between 1997 and 2001. Scand J Urol Nephrol 2006;40:276-82.
5. M. Babjuk, W. Oosterlinck, R. Sylvester, et al. 2009 Guidelines on TaT1 (Non-muscle invasive) Bladder Cancer [online]. http://www.uroweb.org/gls/pdf/TaT1%20(non-muscle%20invasive)%20bladder%20cancer%202010.pdf. Accessed March 8, 2011.
6. Skinner EC. The best treatment for high-grade T1 bladder cancer is cystectomy. Urol Oncol 2007;25:523-5.
7. Denzinger S, Fritsche HM, Otto W, et al. Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladder-sparing approach? Eur Urol 2008;53:146-52.
8. Bianco FJ Jr, Justa D, Grignon DJ, et al. Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy. Urol Oncol 2004;22:290-4.
9. Gupta A, Lotan Y, Bastian PJ, et al; Bladder Cancer Research Consortium. Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy. Urology 2008;71:302-7.
10. Fritsche HM, Burger M, Svatek RS, et al. Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: Results from an International Cohort. Eur Urol 2009.
11. Stein JP, Penson DF. Invasive T1 bladder cancer: indications and rationale for radical cystectomy.[see comment]. BJU Int 2008;102:270-5.
12. Solsona E, Iborra I, Rubio J, et al. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour. BJU Int 2004;94:1258-62.
13. Raj GV, Herr H, Serio AM, et al. Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer. J Urol 2007;177:1283-6.
14. Streeper NM, Simons CM, Konety BR, et al. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer. BJU Int 2009;103:475-9.
15. Kunju LP, You L, Zhang Y, et al. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens. J Urol 2008;180:1928-32.
16. Weizer AZ, Wasco MJ, Wang R, et al. Multiple adverse histological features increase the odds of under staging T1 bladder cancer. J Urol 2009;182:59-65; discussion 65.
17. Kamat AM, Gee JR, Dinney CP, et al. The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma. J Urol 2006;175:881-5.
18. Kwak C, Ku JH, Park JY, et al. Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer. J Urol 2004;171:149-52.
19. Montie JE, Clark PE, Eisenberger MA, et al; National Comprehensive Cancer Network. Bladder cancer. J Natl Compr Cancer Netw 2009;7:8-39.
20. Divrik RT, Sahin A, Altok M, et al. The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer. J Urol 2007;178:802-6.
21. Kibel AS, Dehdashti F, Katz MD, et al. Prospective study of 18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma. J Clin Oncol 2009;27:4314-4320. Epub 2009 Aug 3.